EP0267924A1 - Salpetersäure ester von benzothiazepinonen - Google Patents
Salpetersäure ester von benzothiazepinonenInfo
- Publication number
- EP0267924A1 EP0267924A1 EP19870902370 EP87902370A EP0267924A1 EP 0267924 A1 EP0267924 A1 EP 0267924A1 EP 19870902370 EP19870902370 EP 19870902370 EP 87902370 A EP87902370 A EP 87902370A EP 0267924 A1 EP0267924 A1 EP 0267924A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formula
- benzothiazepine
- dimethylamino
- ethyl
- nitric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Definitions
- the nitric esters of the invention have coronary vasodilatory properties useful for the treatment of angina of various types, relieving pain and improving the blood supply to ischemic heart tissue.
- oxy-acyl derivatives of benzothiazepines currently in use as vasodilators hydrolyze relatively easily in the digestive tract and by hepatic metabolism, so that bioavailability, e.g. 2- (4-methoxyphenyl) -3-oxy-acetyl -5 (2-dimethylamino-ethyl) -2, 3 dihydro-1,5 benzothiazepine-4 (5H) -one is only about 10%.
- the basic property of this benzothiazepine although relatively weak, does not, however, allow good intraepidermal penetration as new galenic preparations would allow.
- the oxy-nitro derivatives of the invention such as: 2- (4-methoxyphenyl) -3-oxy-nitro-5 (2-dimethylamino-ethyl) 2,3 dihydro-1,5 benzothiazepine-4 (5H) - they have great stability in biological media and good diffusion through the epidermis through which they reach the bloodstream for a prolonged period. They can be used by trans-epidermal administration techniques.
- reaction medium is removed from the ice-salt mixture and the reaction continues with magnetic stirring until the medium becomes homogeneous.
- the solution in 50 ml of methylene chloride from the medium is extracted twice with 100 ml of CO 3 HNa at 5% and then twice with 100 ml of water.
- the evaporation residue from the organic solution is taken up in ethyl acetate. This solution is extracted twice with 150 ml of water.
- the organic solution is dried over magnesium sulfate and the solvent evaporated under reduced pressure.
- the amorphous residue is crystallized from water, mp 76-77 °, recrystallized. in ether at -18 °, F. 86-87 °, recrystallization in EtOH at -18 °, F.86-87 °.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1895/86 | 1986-05-09 | ||
| CH189586 | 1986-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0267924A1 true EP0267924A1 (de) | 1988-05-25 |
Family
ID=4221108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19870902370 Withdrawn EP0267924A1 (de) | 1986-05-09 | 1987-05-08 | Salpetersäure ester von benzothiazepinonen |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0267924A1 (de) |
| WO (1) | WO1987006934A1 (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR6915295D0 (pt) * | 1969-01-25 | 1973-04-12 | Tanabe Seiyaku Co | Indicador cronologico de evento em transmissao televisada |
| US4065488A (en) * | 1977-02-24 | 1977-12-27 | American Home Products Corporation | Process for preparing 1,4:3,6-dianhydro-D-glucitol 2-nitrate |
-
1987
- 1987-05-08 EP EP19870902370 patent/EP0267924A1/de not_active Withdrawn
- 1987-05-08 WO PCT/CH1987/000053 patent/WO1987006934A1/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO8706934A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1987006934A1 (fr) | 1987-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0325540A1 (de) | Aromatische Ester und Thioester, ihr Herstellungsverfahren und ihre Anwendung in der Human- oder Tiermedizin und in der Kosmetik | |
| EP0874812B1 (de) | 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung | |
| CA1167047A (fr) | Benzodioxanne l,4 methoxy-2 propanolamines, leur preparation et leur application en tant que medicaments | |
| EP0469984B1 (de) | N-sulphonylindolinderivate, deren Herstellung und diese enthaltende Arzneimittel | |
| JPH0576939B2 (de) | ||
| EP0068998B1 (de) | (Z)-1-Aryl-2-aminomethyl-cyclopropan-carboxylate, ihre Herstellung und ihre Verwendung als Arzneimittel für die Behandlung von verschiedenen Schmerzen | |
| EP0461039B1 (de) | Benzimidazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen | |
| EP0025727B1 (de) | Indol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Medikamente | |
| EP0000299A1 (de) | Neue substituierte 2-Benzoyl-4-chloro-glycinanilidederivate, Verfahren zu ihrer Herstellung und deren Verwendung als Heilmittel. | |
| EP0122827B1 (de) | 1-(2-Ethoxycarbonyl-4-phenylalkylamido)-3-amino-2-Propanole, deren Herstellungen und deren pharmazeutische Verwendungen | |
| EP0304665B1 (de) | 2,4,6-Triaminopyrimidin N-3-oxid-Harnstoff-Derivate, deren Herstellung und deren kosmetische und dermopharmazeutische Verwendung | |
| EP0223674A1 (de) | 7-Acyl-benzoxazinone und deren Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
| EP0267924A1 (de) | Salpetersäure ester von benzothiazepinonen | |
| EP0487423A1 (de) | Benzoselenazolinonderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten | |
| EP0143016B1 (de) | Derivate von 4-(3-Alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phenylacetamid, ihre Herstellung und ihre therapeutische Verwendung | |
| CH656132A5 (fr) | Derives de n-carbamoyl d'isothiazolo-(5,4b) pyridine one-3 leur procede de preparation, et compositions cosmetiques les contenant. | |
| FR2483408A1 (fr) | Esters de derives alcoxyacyliques de la carnitine, leur procede de preparation et compositions pharmaceutiques les contenant | |
| EP0201400A1 (de) | 4-Phenylpropylindolderivate und ihre Salze, Verfahren zur Herstellung, deren Anwendung als Heilmittel und sie enthaltende pharmazeutische Zusammensetzungen | |
| EP0022017A1 (de) | Derivate von 2-Benzoyl-4-nitro-aniliden, deren Herstellung und deren Verwendung als Heilmittel | |
| EP0187096A1 (de) | Arylalcoyloxymethyl-2-morpholine, deren Herstellung und deren Verwendung als Arzneimittel für die Behandlung von Zentralnervensystemstörungen | |
| FR2504925A1 (en) | N-2-amino 3-alkoxy or phenoxy-propyl urea and thiourea derivs. - are cardiovascular agents esp. used to treat arrhythmia | |
| EP0871611B1 (de) | Neue gylcylanilid-derivate, deren herstellung und deren verwendung zur behandlung von hypercholesterolämie und atherosklerose | |
| KR870007911A (ko) | 히드록시인돌 에스테르의 제조방법 | |
| LU86259A1 (fr) | Amides aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique | |
| FR2573755A1 (fr) | Derives polysubstitues du naphtalene, leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19880212 |